Ansell Limited (ANSLF) Q2 2025 Earnings Call Transcript

2025-02-10 09:09:05 ET

Ansell Limited (ANSLF)

Q2 2025 Results Conference Call

February 9, 2025 05:00 PM ET

Company Participants

Neil Salmon - Chief Executive Officer

Zubair Javeed - Chief Financial Officer

Conference Call Participants

David Low - JPMorgan

Craig Wong-Pan - RBC

Saul Hadassin - Barrenjoey

Andrew Paine - CLSA

Vanessa Thomson - Jefferies

Laura Sutcliffe - UBS

Dan Hurren - MST Marquee

Presentation

Operator

Thank you for standing by, and welcome to the Ansell Limited FY '25 Half Year Results Call. [Operator Instructions]

I would now like to hand the conference over to Mr. Neil Salmon, CEO. Please go ahead.

Neil Salmon

Thank you, and thank you to all of you for your continued interest in Ansell as we update you on our progress over the last 6 months. And let me begin with a slide that summarizes the content we'll cover today and also what I hope you will find are the key takeaways from our current performance as a business.

Firstly, in terms of performance overview, and I'm very satisfied to report double-digit top and bottom line growth, and that's come as a result of meeting or exceeding all our FY '25 first half year performance objectives. Significant as part of that, our results from the 2 major investments we've made: The acquisition of the KBU and our productivity program. Both those are on or ahead of the goals that we previously communicated to you. Also significant to the result is our continued focus on what we consider to be our drivers of long-term growth and sustainability, and I'll outline how we continue to invest behind those.

I'll then hand over to Zubair, who will summarize how that comes together in a strong financial performance and also an increasing balance sheet flexibility, all of which gives me confidence today to increase our overall EPS guidance range for the year. Having summarized that, we'll then give you an opportunity to ask us questions.

So to that performance overview. And as is our pattern on the left-hand side of the page here are the goals that I communicated to you at the beginning of the fiscal year. In the middle is my progress assessment against those with summary financials to the right.

So the key, as we began the year, was to maintain improved organic sales growth in Industrial and see Healthcare return to organic growth. So certainly accomplish both those goals. Very pleased with the 16% organic growth in Healthcare and the 8% growth in Industrial. Healthcare is clearly showing evidence that the destocking effects for the last couple of years are firmly behind us, but we also saw some benefit from the catch-up of delayed surgical orders that we communicated to you 6 months ago had been deferred from June fiscal year '24. Industrial success largely driven by new products....

Read the full article on Seeking Alpha

For further details see: